Stephane Giraudier (Stéphane Giraudier)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Venues

Leukemia

American journal of hematology

Blood cancer journal

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Emeline Voirin, Anne Bouvier, Isabelle Plo, Léa Durix, Annaëlle Beucher, Stephane Giraudier, Valérie Ugo, Jean-François Brasme, Damien Luque Paz
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis. American journal of hematology (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Emeline Voirin, Anne Bouvier, Isabelle Plo, Léa Durix, Annaëlle Beucher, Stephane Giraudier, Valérie Ugo, Jean-François Brasme, Damien Luque Paz
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis. American journal of hematology 99 (8) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology 99 (4) (2024)
Panhong Gou, Duanya Liu, Saravanan Ganesan, Evelyne Lauret, Nabih Maslah, Veronique Parietti, Wenchao Zhang, Véronique Meignin, Jean-Jacques Kiladjian, Bruno Cassinat, Stephane Giraudier
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Emeline Voirin, Anne Bouvier, Isabelle Plo, Léa Durix, Annaëlle Beucher, Stephane Giraudier, Valérie Ugo, Jean-François Brasme, Damien Luque Paz
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis. American journal of hematology 99 (8) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Emeline Voirin, Anne Bouvier, Isabelle Plo, Léa Durix, Annaëlle Beucher, Stephane Giraudier, Valérie Ugo, Jean-François Brasme, Damien Luque Paz
Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis. American journal of hematology 99 (8) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia 38 (7) (2024)
Nabih Maslah, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia (2024)
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM. American journal of hematology (2024)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia (2023)
Christophe Willekens, Lucie Laplane, Tracy Dagher, Camelia Benlabiod, Nicolas Papadopoulos, Catherine Lacout, Philippe Rameau, Cyril Catelain, Alexia Alfaro, Valérie Edmond, Nicolas Signolle, Valentine Marchand, Nathalie M Droin, Remco Hoogenboezem, Rebekka K Schneider, Alex Penson, Omar Abdel-Wahab, Stephane Giraudier, Florence Pasquier, Caroline Marty, Isabelle Plo, Jean-Luc J-L Villeval, Stefan N Constantinescu, Françoise Porteu, William Vainchenker, Eric Solary
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice. Leukemia (2023)
Nabih Maslah, Lina Benajiba, Stephane Giraudier, Jean-Jacques Kiladjian, Bruno Cassinat
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Dikelele Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, Nabih Maslah, Juliette Soret-Dulphy, Emmanuelle Verger, Clémence Marcault, Nathalie Parquet, Pierre Fenaux, Lionel Ades, Emmanuel Raffoux, Stephane Giraudier, Olivier Fain, Bruno Cassinat, Jean-Jacques Kiladjian, Arsenne Mekinian, Lina Benajiba
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID). Leukemia (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stephane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benajiba
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 38 (2) (2023)
Emmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, Christine Chomienne, Jean-Jacques Kiladjian, Stephane Giraudier, Bruno Cassinat
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patients. International journal of laboratory hematology 42 (6) (2020)
Olivier Mansier, Damien Luque Paz, Jean-Christophe Ianotto, Yannick Le Bris, Aurélie Chauveau, Françoise Boyer, Carole Conejero, Olivier Fitoussi, Jérémie Riou, Didier Adiko, Mohamed Touati, Jasmine Chauzeix, Jean-François Viallard, Marie C Béné, Stephane Giraudier, Valérie Ugo, Eric Lippert
Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study. American journal of hematology 93 (4) (2018)
Nicolas Partouche, Carole Conejero, Quentin Barathon, Julien Moroch, Michel Tulliez, Catherine Cordonnier, Stephane Giraudier
Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone. Hematological oncology 36 (1) (2017)

Stephane Giraudier.css-eqlu8i{font-size:small;padding-left:4px;} (Stéphane Giraudier)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephane Giraudier (Stéphane Giraudier)